| Approved? (Admin-only) |
|
|---|---|
| Opportunity Type | Funding Opportunity Announcement (FOA) |
| Funding Opportunity Posted By | DOD |
| Component | DHA - CDMRP |
| Funding Opportunity Title | CDMRP Tick-Borne Disease Research Program (TBDRP) |
| Opportunity ID | HT942526TBDRPTDRA, HT942526TBDRPTDRA |
| Link to Funding Opportunity | ebrap.org |
| Funding Opportunity Short Description | Tick-Borne Disease Research Program (TBDRP) |
| Important Dates | |
| Open Date | 05/05/2026 |
| White Paper / Pre-Proposal / Solution Summary Due | 07/22/2026 |
| Full Applications Due | 10/22/2026 |
| Funding Details | |
| Funding Mechanism |
|
| Eligibility |
|
| Assistance Listings | 12.420 -- Military Medical Research and Development |
| Required Registrations |
|
| Funding Opportunity Full Description | The intent of the fiscal year 2026 (FY26) Tick-Borne Disease Research Program (TBDRP) Idea Development Award (IDA) is to support conceptually innovative research that could lead to impactful discoveries or significant advancements that will accelerate progress toward reducing the burden of Lyme disease and/or other tick-borne diseases and conditions, and improving patient care and/or the quality of life. Applications should propose research that is conceptually innovative, introduces a new concept or question, challenges existing paradigms, approaches issues from a new perspective, or exhibits other uniquely creative qualities; and should not merely be a next logical step or an incremental advance on published data or ongoing research. The intent of the fiscal year 2026 (FY26) Tick-Borne Disease Research Program (TBDRP) Therapeutic/Diagnostic Research Award (TDRA) is to support product-driven therapeutic and diagnostic development research aimed at reducing the burden of Lyme disease and/or other tick-borne diseases and conditions, and improving patient care and/or quality of life. Treatment-focused applications should be therapeutic evaluation studies designed to advance new ideas aimed at drug or treatment discovery that are still in the early/preclinical stages of development. Diagnosis-focused applications should propose diagnostic approaches that will be readily integrated into clinical settings. |
